Once Again A Blood Pressure Medication Recall For Cancer Concerns
Yet another blood pressure medication is being recalled due to the presence of impurities that could cause cancer.…
FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine
Teva Pharmaceutical Industries Ltd FDA approves single-dose AJOVY® (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in…